Cooperative Agreement NU2GGH002484

The U.S. Centers for Disease Control and Prevention (CDC) has awarded a $10,151,871 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to the University of California, San Francisco (UCSF) to lead the Alliance for Country-Led Control of the HIV Epidemic by Leveraging Efficient Resource Allocation to Achieve Equity (ACCELERATE) consortium. This 4-year award, effective September 30, 2024, aims to promote sustainable, data-driven, and equitable HIV/AIDS programs in Kenya, Uganda,...

This $365,253 Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the USAID Foreign Assistance for Programs Overseas (CFDA 98.001) program supports the "CHILDREN, ADOLESCENTS AND FAMILIES IN THE HIV EPIDEMIC (CAFHE) IN THE FREE STATE" program. The five-year award, running from November 2024 to November 2029, is being implemented by the non-profit organization National Institute Community Development And Management (Nicdam) based in South Africa....

This $244,814 Project Grant award from the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) will fund a mixed-methods research study to investigate the social and behavioral drivers of HIV risk among South African adolescent girls and young women (SA-AGYW). The primary objectives are to: 1) conduct secondary analyses of baseline data from an existing HIV prevention intervention to examine the roles of mental health...

The National Institute of Mental Health (NIMH) awarded a $780,447 Project Grant (CFDA 93.242 - Mental Health Research Grants) to Brigham & Women's Hospital Inc. to test a differentiated service delivery model called CARES-DSD to improve engagement and viral suppression among people with HIV who have experienced treatment interruptions in South Africa. The 5-year project will recruit 300 participants from an ongoing study and evaluate the effectiveness of the CARES-DSD intervention compared...

This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $672,913 to The Trustees of Columbia University in the City of New York to conduct the "ENHANCING NOVEL RESEARCH FOR INFLAMMATION AND COGNITIVE HEALTH AMONG ADOLESCENTS AND YOUNG ADULTS LIVING WITH PERINATALLY ACQUIRED HIV AND ADVERSITY (ENRICH+)" study. The key objectives of this 5-year project...

This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), aims to increase HIV and substance use prevention and treatment among adolescent and young adult (AYA) survivors of sexual violence. The $1,344,412 award will fund a 3-year project to: 1) tailor existing Sexual Assault Nurse Examiner (SANE) services with same-day HIV prophylaxis and substance use prevention, 2) optimize study mechanisms and outcome...

The Centers for Disease Control and Prevention (CDC) awarded a $3,710,204 Cooperative Agreement under the Global AIDS program (CFDA 93.067) to Humana People To People Congo (HPP-Congo), a non-profit organization based in the Democratic Republic of the Congo (DRC). The award, titled "TOTAL CONTROL OF THE EPIDEMIC TCE KINSHASA", will fund a 5-year project (2024-2029) to strengthen HIV/TB prevention, detection, and treatment services in Kinshasa Province, DRC. Key objectives include...

This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $381,487 to the University of Maryland, Baltimore (UMB) to assess the early implementation of long-acting injectable cabotegravir (CAB-LA) pre-exposure prophylaxis (PrEP) among adolescent girls and young women (AGYW) at high risk of HIV acquisition in Zambia. The key objectives are to: 1) Evaluate implementation determinants of CAB-LA...

This $15,221,142 Cooperative Agreement award, issued by the Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067), aims to develop, implement, and sustain high-quality comprehensive facility and community-based HIV 95-95-95 cascade activities for children, adolescents, and adults in Cameroon. The five-year project, implemented by the Association Camerounaise Pour LE Marketing Social (ACMS), seeks to achieve the UNAIDS 95-95-95 goals and contribute to...

This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), aims to adapt and evaluate the effectiveness of the Comprehensive Adherence Resource and Empowerment Support (CARES) intervention to increase pre-exposure prophylaxis (PrEP) continuation and adherence among adolescent girls and young women in South Africa and Zimbabwe. The total funding amount is $710,187, with an award date of September 11, 2024 and an...